A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per Modified Mayo Score at Week 12.
Epistemonikos ID: 4ffba3cda9b63e747be411e884c589e87312ee4e
First added on: Mar 12, 2026